Publications by authors named "Shihui Ren"

Claim this Profile
C
CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis.
Ying He, Ling Qiu, Dan Chen, Shi-Hui Ren, Ya-Xin Xiong

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial.
Hao Yao, Shi-Hui Ren, Lin-Hui Wang, Ming-Qiang Ren, Jiao Cai

J Hematol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial.
Hao Yao, Shi-Hui Ren, Lin-Hui Wang, Ming-Qiang Ren, Jiao Cai

J Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid development of acute monocytic leukemia (AML-M5b) with t(9;11)(p22;q23) after chemotherapy for T-cell lymphoblastic lymphoma: A case report.
Jiao Cai, Nan Zhang, Ling Qiu, Bai-Tao Dou, Meng-Jiao Li, Shi-Hui Ren

Heliyon· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application value of metagenomic next-generation sequencing in hematological patients with high-risk febrile neutropenia.
Xiao Wang, Huiye Zhang, Nan Zhang, Shan Zhang, Yanrong Shuai, Shihui Ren

Front Cell Infect Microbiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenic marginal zone lymphoma with monoclonal IgG: A case report.
Xupai Zhang, Shihui Ren, Nan Zhang, Xiao Wang, Lin Qiu

Medicine (Baltimore)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy.
Baitao Dou, Shihui Ren, Ling Qiu, Xupai Zhang, Nan Zhang

Front Med (Lausanne)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy.
Hao Yao, Lei Cheng, Dan Chen, Qian Zhang, Ling Qiu, Shi-Hui Ren

Expert Rev Anticancer Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis